Joslin's New Ceo Announced
October 5, 2015
Starting on October 5th, Dr. Peter Amenta will become the new Joslin President and CEO. Where previous CEO John Brooks background was as a businessman and entrepreneur, Amenta is a long-term clinician and research scientist. A few highlights on his background:
- Currently a Professor of Pathology and Laboratory Medicine at Rutgers Robert Wood Johnson Medical School
- Over a 20 year career, he held a number of administrative positions at Robert Wood Johnson, including Chief of Staff and Dean of the Medical School.
- He is regarded as an expert microscopist and immunohistochemist, and is widely published.
A change in leadership such as this signals a shift in strategic direction. However, to date, there is no statement on the key reason for the change in leadership nor has their been a statement from the board of directors about what changes that want to achieve with this change.